ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2256

Histopathologic Features and Tissue Interferon-Response Gene Scoring of Lesional Skin Samples for Diagnosis in Autoinflammatory Disorders

Kyawt W. Shwin1,2, Chyi-Chia Richard Lee3, Adriana Almeida de Jesus4, Carmelo Carmona-Rivera5, Louise Malle4, Yanfeng Hou6, Gina A. Montealegre Sanchez4, Edward Cowen7 and Raphaela Goldbach-Mansky8, 1Translational Autoinflammatory Diseases Studies, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, 2National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, 3Dermatopathology Section, Laboratory of Pathology, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, 4National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, 5Systemic Autoimmunity Branch/ NIAMS, National Institutes of Health, Bethesda, MD, 6Translational Autoinflammatory Disease Studies, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, 7Dermatology Branch, National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD, 8Translational Autoinflammatory Disease Studies, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Autoinflammatory Disease, IL-1, Immune Dysregulation, interferons and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Innate Immunity and Rheumatic Disease - Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Many genetically defined autoinflammatory diseases (AID) are caused by innate immune dysregulation and present with “neutrophilic dermatoses”. This study systematically assesses immune-cell infiltrates, and interferon (IFN) scores in skin biopsies of 2 IFN-mediated AID: STING-Associated Vasculopathy with onset in Infancy (SAVI) and Chronic Atypical Neutrophilic Dermatosis with Lipodystrophy and Elevated Temperature (CANDLE) and 2 IL-1-mediated AID, Neonatal-onset Multisystem Inflammatory Disease (NOMID) and Deficiency of IL-1 Receptor Antagonist (DIRA). We hypothesize that histopathologic and immunologic features present in skin lesions can distinguish IFN- from IL-1-mediated disorders.

Methods: Tissue from skin lesions of patients with NOMID (n=4), DIRA (n=4), SAVI (n=3), CANDLE (n=5) and other interferonopathies (UIFN) (n=7) were stained with H&E. Immunohistochemistry with antibodies to Myeloperoxidase (MPO/Neutrophil), CD163 (macrophage), CD123 (plasmacytoid dendritic cell (pDC)), CD3 (T cell), CD19 (B cells) was performed. The presence of Neutrophil extracellular traps (NETs, citrullinated histone H4) and IFN-inducible protein (Mx1) were assessed by immunofluorescence. An RNA IFN score was obtained. Inflammatory cells in skin regions were semi-quantitatively scored: 0=absent, 1=scant, 2=moderate or 3=abundant.

Results:

Clinically, NOMID patients present with urticaria, DIRA with pustulosis, CANDLE with nodular rashes and SAVI with acral violaceous vasculitic plaques. Histochemically, dense MPO+ cells within intraepidermal microabscesses were seen only in DIRA. In CANDLE, MPO+ and CD163+ cells were noted predominantly in the deep dermis and sucutis. SAVI had intravascular thrombi, fibrinoid necrosis of vascular wall with abundant perivascular MPO+ and CD163+ cells. Nuclear debris was seen in SAVI and CANDLE. Mild CD123+ cells were seen in dermis and perivascular areas in SAVI and CANDLE; but not in DIRA and rarely in one NOMID sample. CD3+ cells were seen predominantly in dermis and perivascular areas in SAVI, and in periadnexal areas in CANDLE. Dermal CD19+ cells were noted only in a patient with long-standing SAVI. The presence of NETs was evident in NOMID, DIRA and CANDLE, but not in SAVI. SAVI and CANDLE samples have positive Mx-1 staining and high IFN-response gene scores, but not in NOMID and DIRA.

Conclusion: A distinct histologic pattern of neutrophil and macrophage infiltration characterizes SAVI, CANDLE, NOMID and DIRA skin biopsies, while Mx-1 staining and the IFN score distinguish IFN- and IL-1 mediated AID. Thus, the histologic and immunologic assessment of skin biopsies may guide the diagnosis and identify dysregulated immune pathways in AID. Furthermore the skin can serve as a tissue model to evaluate molecular pathways that lead to the skin manifestations in genetically defined and undefined inflammatory diseases.


Disclosure: K. W. Shwin, None; C. C. R. Lee, None; A. Almeida de Jesus, None; C. Carmona-Rivera, None; L. Malle, None; Y. Hou, None; G. A. Montealegre Sanchez, None; E. Cowen, None; R. Goldbach-Mansky, None.

To cite this abstract in AMA style:

Shwin KW, Lee CCR, Almeida de Jesus A, Carmona-Rivera C, Malle L, Hou Y, Montealegre Sanchez GA, Cowen E, Goldbach-Mansky R. Histopathologic Features and Tissue Interferon-Response Gene Scoring of Lesional Skin Samples for Diagnosis in Autoinflammatory Disorders [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/histopathologic-features-and-tissue-interferon-response-gene-scoring-of-lesional-skin-samples-for-diagnosis-in-autoinflammatory-disorders/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/histopathologic-features-and-tissue-interferon-response-gene-scoring-of-lesional-skin-samples-for-diagnosis-in-autoinflammatory-disorders/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology